# Editorial: Advances in identifying individuals at clinical high risk (CHR) for psychosis: perspectives from North America

**Authors:** Sarah I. Tarbox-Berry, Daniel J. A. Devoe, Rishab Gupta

PMC · DOI: 10.3389/fpsyt.2023.1357838 · Frontiers in Psychiatry · 2024-01-16

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}
- **Diseases:** trauma (MESH:D014947), functional impairment (MESH:D003072), CHR (MESH:D000075902), decreased expression of emotion (MESH:D001039), social anhedonia (MESH:D059445), perceptual abnormalities (MESH:D010468), Stress (MESH:D000079225), Psychosis-Risk Syndromes (MESH:D011618), DD (MESH:C536170), PNS (MESH:D064726), CHR symptoms (MESH:D012816), schizophrenia (MESH:D012559)
- **Chemicals:** OT (MESH:D010121)
- **Cell lines:** ST-B — Homo sapiens (Human), Lung non-small cell carcinoma, Cancer cell line (CVCL_7025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10824947/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC10824947/full.md

---
Source: https://tomesphere.com/paper/PMC10824947